Validated biomarker assays confirm that <scp>ARID1A</scp> loss is confounded with <scp>MMR</scp> deficiency, <scp> CD8 <sup>+</sup> TIL </scp> infiltration, and provides no independent prognostic value in endometriosis‐associated ovarian carcinomasKarolin Heinze, Yurii B. Shvetsov, Nicola S. Meagher et al.|The Journal of Pathology|2021Cited by 42
p53 and ovarian carcinoma survival: an Ovarian Tumor Tissue Analysis consortium studyMartin Köbel, Jaime Lesnock, Eunyoung Kang et al.|The Journal of Pathology Clinical Research|2023Cited by 29
Gene-Expression Profiling of Mucinous Ovarian Tumors and Comparison with Upper and Lower Gastrointestinal Tumors Identifies Markers Associated with Adverse OutcomesNicola S. Meagher, Kayla Klett, Kylie L. Gorringe et al.|Clinical Cancer Research|2022Cited by 22
Prognostic and Immunological Significance of ARID1A Status in Endometriosis-Associated Ovarian CarcinomaKarolin Heinze, Yurii B. Shvetsov, Tayyebeh M. Nazeran et al.|medRxiv|2021Cited by 4